Medical Disclaimer: Vitalis provides validated clinical screening tools and evidence-based self-advocacy guides for individuals and couples. Data stays 100% on your device.Privacy-First Architecture
Perimenopausal hormone shifts alter central nervous system signaling, sleep architecture, and metabolic regulation. Vitalis Her combines validated medical screening (MRS, PHQ-9, GAD-7) with birth control interaction logic and transdermal safety data.
Validated Medical Assessment
Menopause Rating Scale (MRS) Assessment
0% Complete
Clinical Scale Overview: The Menopause Rating Scale (MRS) is an internationally validated 11-item diagnostic tool covering Somato-Vegetative, Psychological, and Urogenital domains. Rate severity over the past 30 days (0 = None to 4 = Very Severe).
Neuroendocrine Mechanisms of Perimenopausal Symptoms
During perimenopause, ovarian follicle depletion leads to erratic 17β-estradiol and progesterone fluctuations. These biochemical swings alter central neuroreceptor networks and biological systems:
Hypothalamic Thermoregulation
Estrogen drop destabilizes KNDy neurons in the infundibular nucleus, narrowing the brain's neutral thermal zone and triggering flushing and night sweats.
GABA-A Neurosteroid Withdrawal
Progesterone drops eliminate allopregnanolone modulation of GABA-A receptors, triggering unprovoked panic and abrupt 3 AM awakenings.
Serotonin & Dopamine Signaling
Lower estradiol reduces tryptophan hydroxylase activity, decreasing synaptic serotonin density and precipitating mood lability and fatigue.
Cerebral Bioenergetics & Brain Fog
Estradiol regulates glucose transport (GLUT1/3) in cerebral mitochondria. Falling levels drop brain ATP production by 20–25%, causing cognitive lags.
Diagnostic Summary
MRS Score Overview
Total Symptom Burden
0/ 44
Minimal Burden (0-4)
STRAW+10 Reproductive Stage
Late Reproductive (Stage -3)
Predictable cycles; subtle early hormone fluctuations.
Tailored Strategy:
• Complete symptom ratings on the left to generate customized guidance.
Analytics
Daily Symptom & Mood Trend Log
Single-day snapshots can mislead due to hormone volatility. A 7-day rolling average provides accurate baselines.
7-Day Rolling Trend Line
Integration Logic
Birth Control & HRT Compatibility Matrix
Natural Cycles Selected
Endogenous gonadotropin signaling is unmasked. Cycle shifts of ≥ 7 days confirm STRAW Stage -2.
Suppresses FSH/LH. Bleeds are artificial withdrawal events.
Unsafe to Stack
Stacking HRT on COCP increases VTE risk. Must transition off COCP or switch to Mirena prior to HRT.
Levonorgestrel 52mg IUD (Mirena)
Local endometrial suppression; natural FSH/LH cycles remain active.
Gold Standard Partner
Provides up to 5 years of endometrial protection. Clinician adds transdermal 17β-estradiol gel/patch.
Copper IUD / Barrier
Zero hormonal interference. Natural cycles visible for staging.
Fully Compatible
Ideal for body-identical HRT (transdermal 17β-estradiol + oral micronized progesterone).
Directory
Modern Bioidentical HRT & Supplement Protocols
Transdermal Estrogen
17β-Estradiol Patches & Gels
Molecularly identical to human estradiol. Bypasses liver first-pass metabolism, avoiding blood clot factor elevation.
Uterine Protection
Oral Micronized Progesterone
Body-identical progesterone (Utrogestan). Metabolizes into allopregnanolone for natural sedation when taken at bedtime.
Androgen Protocol
Transdermal Testosterone Cream
Indicated for persistent low libido (HSDD). Female dosing (~1/10th male dose) restores motivation and physical recovery.
Local Pelvic Care
Vaginal Estriol / Estradiol
Ultra-low-dose local creams or pessaries targeting Genitourinary Syndrome (GSM). Rebuilds tissue with zero systemic absorption.
Progestogen Safety & Molecular Breakdown
Progestogen Type
Molecular Structure
VTE & Breast Density Risk
Central Nervous System Effect
Micronized Progesterone (Utrogestan)
Body-Identical (C₂₁H₃₀O₂)
Neutral VTE Risk
Metabolizes to allopregnanolone; supports sleep and calms anxiety.
Medroxyprogesterone Acetate (MPA)
Synthetic 17-hydroxyprogesterone derivative
Elevated Breast Density & VTE Risk
Glucocorticoid binding can trigger fluid retention and blunted mood.
Self-Advocacy
Doctor Conversation Kit & Medical Checklist
Clinical Scripts
"Doctor, I am tracking my symptoms using the Menopause Rating Scale (MRS). My score is 0/44, indicating significant quality-of-life impairment. International guidelines (NAMS/IMS) state perimenopause diagnosis in women over 45 is clinical; I would like to evaluate transdermal 17β-estradiol and oral micronized progesterone."
Baseline Lab Checklist
• Serum Ferritin: Target > 50–70 µg/L. Heavy bleeding depletes iron reserves long before anemia registers on hemoglobin.
• Full Thyroid Panel: TSH, Free T3, Free T4, TPO Antibodies (rules out Hashimoto's thyroiditis).
If you are experiencing severe distress or panic, connect with immediate support. USA/Canada: 988 | UK: 111 / 116 123 | South Africa: 0800 567 567 | Australia: 13 11 14.
Sensory Grounding Protocol (5-4-3-2-1)
When sudden neurosteroid withdrawal triggers panic, engage tactile sensory grounding: Name 5 things you see, 4 things you feel, 3 things you hear, 2 things you smell, and repeat: "This is a transient neurochemical shift. I am safe."
Personal Health Profile & Data Ownership
Nutrition, Resistance Training & Sleep Protocols
Protein Target (1.2–1.6 g/kg)
Counteracts muscle loss (sarcopenia) and anabolic resistance caused by lower estrogen.
Axial Loading Exercise (2-3x/week)
Heavy mechanical resistance (squats, deadlifts) stimulates bone remodeling to preserve trabecular bone density.
International Guidelines & PubMed Citations
• ESTHER Study (Transdermal Estradiol Safety): Canonico M, et al. Non-elevated VTE risk with transdermal vs oral estrogen. [PubMed PMID: 17309930]
• STRAW+10 Staging System: Harlow SD, et al. Gold-standard framework for staging female reproductive aging. [PubMed PMID: 22415303]
Validated Androgen Assessment
ADAM Scale (Androgen Deficiency in Aging Males)
0% Complete
Developed by Saint Louis University. Answering "Yes" to Q1 (Libido) or Q7 (Erectile Strength), OR any 3 non-specific items indicates a positive screen.
Pathophysiology of Male Age-Related Androgen Decline
Male androgen decline involves a ~1% annual drop in total testosterone paired with rising Sex Hormone-Binding Globulin (SHBG). This decreases free bioavailable testosterone, impacting nuclear receptor signaling across multiple systems:
Mitochondrial ATP & Protein Synthesis
Testosterone stimulates mitochondrial biogenesis in skeletal muscle. Lower levels lead to physical fatigue and extended workout recovery times.
Dopaminergic Focus & Drive
Androgens regulate dopamine synthesis in the prefrontal cortex. Declining bioavailable testosterone reduces executive focus and drive.
Androgen Screener Status
ADAM Positive Indicators
0/ 10
Negative Screen
Endocrine Action Items:
• Complete questions to evaluate testosterone baseline indicators.
Analytics
Male Vitality & Energy Trend Log
Track morning drive, exercise recovery, and sleep consistency over 7-day rolling windows.
Essential cofactor for Leydig cell androgen production.
Vitamin D3 (3000–5000 IU)
Supports nuclear androgen receptor expression
High Evidence
Optimizes androgen receptor density when paired with Vitamin K2.
Self-Advocacy
Male Doctor Conversation Kit & Baseline Panel
Clinical Scripts
"Doctor, based on my ADAM screening score of 0/10, I would like to order a fasting 7:00 AM – 10:00 AM endocrine panel including Total Testosterone, Free Testosterone (equilibrium dialysis), SHBG, LH, and sensitive Estradiol."
• Safety Screening: Full Blood Count (Hematocrit) & Serum PSA.
Male Mental Health & Stress Resilience
Immediate Professional Crisis Care:
If you are experiencing severe depression or mental health crisis, connect with support. USA/Canada: 988 | UK: 111 | South Africa: 0800 567 567 | Australia: 13 11 14.
Essential for muscle protein synthesis, tissue repair, and supporting endocrine health.
Androgen Clinical Directory
• Androgen Society: Clinical practice guidelines for male testosterone therapy.
• Endocrine Society: Guidelines on Testosterone Therapy in Men with Hypogonadism.
Dual Alignment Portal
Couples Hormonal Cross-Analysis & Heatmap
Shared Synchronization
Partner Scores Real-Time Comparison
Vitalis Her (MRS Burden)Burden Score: 0 / 44
0
Vitalis Him (ADAM Scale)Positive Items: 0 / 10
0
Normalized Symptom Friction Index
Mutual Alignment
Intimacy, Libido Asymmetry & Communication Protocols
Challenge Domain
Hormonal Drivers
Relational Impact
Actionable Alignment Protocol
Libido Mismatch
Female estradiol/testosterone drop + male free testosterone decline.
Misinterpreted as rejection or lost attraction.
Shift focus from spontaneous desire to responsive desire via low-pressure physical touch.
Pelvic Discomfort (GSM)
Local urogenital estrogen atrophy causing vaginal dryness and tissue fragility.
Avoidance of physical intimacy due to fear of pain.
Combine local vaginal estriol/estradiol with high-grade osmotically balanced lubricants.
Couples Advocacy
Joint Appointment Script & Combined Lab Checklist
Joint Conversation Script
"Doctor, as a couple we are systematically tracking our health using validated screening tools. We want to align our individual treatment plans—transdermal body-identical HRT for her and a morning endocrine evaluation for him—to support our overall household vitality."